title: Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model.
abstract: OBJECTIVE
  We have previously reported that the hepatic protein synthesis rate, calculated as the uptake rate of L-[4.5 3H] leucine by the protein fraction during a 10-min incubation of a 16-G needle biopsy specimen of liver tissue, represents a high level of liver function and is therefore useful for evaluating liver function. We investigated the hepatic protein synthesis rate level in a pre-transplant liver to learn if it might predict the outcome in a rat orthotopic liver transplantation model.
  
  
  METHODS
  Grafts were stored, liver specimens were obtained using a 21-G Chiba type II skinny needle, and the hepatic protein synthesis rate was calculated. Subsequently, liver transplantation was performed, and the hepatic protein synthesis rate level of revascularized liver, tissue blood flow rate, serum alanine aminotransferase, lactate dehydrogenase, hyaluronic acid, ketone body rate, and 2-week survival were examined.
  
  
  RESULTS
  The hepatic protein synthesis rate of pretransplant liver was correlated with parameters of post-transplant liver function: hepatic protein synthesis rate of the revascularized liver (r=0.92, p<0.0001), tissue blood flow rate (r=0.77, p<0.004), serum alanine aminotransferase (r=-0.69, p<0.003), lactate dehydrogenase (r=-0.54, p<0.03), hyaluronic acid (r=-0.86, p<0.0002), and ketone body rate (r=0.57, p<0.02). Pretransplant hepatic protein synthesis rate in survivors was 263.6+/-54.2 nmol/mg protein/10 min, while that in nonsurvivors was significantly lower at 162.0+/-39.0 (p<0.0001). When evaluation was made using a logistic regression model, the accuracy predicted using the value of hepatic protein synthesis rate was 95% (19/20).
  
  
  CONCLUSIONS
  These results suggest that measuring the hepatic protein synthesis rate of the grafts with a 21-G Chiba type II skinny needle may be a predictive criterion in the assessment of graft viability.
authors.affiliation: Second Department of Surgery, Chiba University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Matsui
authors.forename: T
authors.initials: T
authors.lastname: Asano
authors.forename: T
authors.initials: T
authors.lastname: Nakagohri
authors.forename: Y
authors.initials: Y
authors.lastname: Tokoro
authors.forename: O
authors.initials: O
authors.lastname: Kainuma
authors.forename: T
authors.initials: T
authors.lastname: Kenmochi
authors.forename: K
authors.initials: K
authors.lastname: Isono
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001783:Blood Flow Velocity; D003080:Cold Temperature; D006085:Graft Survival; D006820:Hyaluronic Acid / Q000097:blood; D007511:Ischemia / Q000378:metabolism*; D007657:Ketone Bodies / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008099:Liver / Q000098:blood supply / Q000378:metabolism*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods / Q000401:mortality; D008297:Male; D011237:Predictive Value of Tests; D011506:Proteins / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012044:Regression Analysis; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007657:Ketone Bodies; D011506:Proteins; D006820:Hyaluronic Acid; D007770:L-Lactate Dehydrogenase; D000410:Alanine Transaminase